Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
|
|
MyMD Pharmaceuticals, Inc. (AKER)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Iroquois Capital Management, LLC reports a 6.5% stake in MyMD Pharmaceuticals, Inc. |
| 02/23/2022 |
SC 13G/A
| Iroquois Capital Management, LLC reports a 9.6% stake in MyMD Pharmaceuticals, Inc. |
| 02/11/2022 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 1% stake in MyMD Pharmaceuticals, Inc. |
| 01/11/2022 |
SC 13G/A
| MAINFIELD ENTERPRISES INC reports a 0% stake in MyMD Pharmaceuticals, Inc. |
| 02/22/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/29/2021 |
SC 13G/A
| INTRACOASTAL CAPITAL, LLC reports a 7.5% stake in Akers Biosciences, Inc. |
| 11/19/2020 |
SC 13G/A
| Iroquois Capital Management, LLC reports a 10% stake in AKERS BIOSCIENCES, INC. |
| 05/05/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 04/20/2020 |
SC 13G/A
| ALPHA CAPITAL ANSTALT reports a 4.2% stake in AKERS BIOSCIENCES, INC. |
| 12/11/2019 |
SC 13G/A
| ALPHA CAPITAL ANSTALT reports a 10% stake in AKERS BIOSCIENCES, INC. |
| 01/30/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/10/2019 |
SC 13G/A
| Empery Asset Management, LP reports a 5% stake in Akers Biosciences, Inc. |
| 07/26/2018 |
SC 13G/A
| ALPHA CAPITAL ANSTALT reports a 0% stake in AKERS BIOSCIENCES, INC. |
| 05/07/2018 |
SC 13G/A
| BIGGER CAPITAL FUND L P reports a 1% stake in Akers Biosciences, Inc. |
| 02/13/2018 |
SC 13G/A
| BIGGER CAPITAL FUND L P reports a 6.2% stake in Akers Biosciences, Inc. |
| 01/18/2018 |
SC 13G/A
| Empery Asset Management, LP reports a 10% stake in Akers Biosciences, Inc. |
| 01/25/2016 |
SC 13G/A
| ACT Capital Management, LLLP reports a 3.9% stake in Akers Biosciences, Inc. |
| 01/23/2015 |
SC 13G/A
| ACT Capital Management, LLLP reports a 7.3% stake in Akers Biosciences, Inc. |
|
|